Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

OHI vs HR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

OHI Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–3 Matrix Metrics)

OHI Overall Winner 6-Pillar Tally: OHI 4 – 2 HR Matrix Metrics: OHI 6 – 3 HR

As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over Healthcare Realty Trust Incorporated (HR) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas HR carries 43.3/100 (HOLD) at $19.27 (10.8x Forward P/E, 13.2% operating margin).

  • Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile HR trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 64.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About OHI vs HR
OHI NYSE Head-to-Head Winner
Omega Healthcare Investors Inc.
Real Estate Investment Trusts
$46.91
-0.29% 1D
Market Cap $15.0B
TTM Revenue $1.26B
Forward P/E 22.6x
Beta / 30D Vol -0.04β · 29% Vol
Unified Composite Score
50.5 / 100 HOLD
Tech 50.0 Fund 55.0 Flow 71.0 Mom 41.7
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope 0.5%) with fading momentum, RSI 50
RSI-14: 49.6 · SMA20: $47.08 · SMA50: $46.44
HR NYSE
Healthcare Realty Trust Incorporated
Real Estate Investment Trusts
$19.27
-0.26% 1D
Market Cap $6.7B
TTM Revenue $1.14B
Forward P/E 10.8x
Beta / 30D Vol 0.11β · 29% Vol
Unified Composite Score
43.3 / 100 HOLD
Tech 33.0 Fund 40.0 Flow 48.0 Mom 41.1
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 64
RSI-14: 64.1 · SMA20: $18.64 · SMA50: $18.18

6-Pillar Scorecard Institutional Category Breakdown (OHI 4 – 2 HR)

Columns: Metric · OHI · HR
1. Valuation Multiples HR
Forward P/E 22.6x 10.8x
Trailing P/E 19.0x 10.8x
PEG Ratio 11.99x 8.82x
EV / Revenue 14.9x 9.8x
2. Growth & Scale OHI
Revenue Growth (YoY) -0.6% -3.6%
Earnings Growth (YoY) -55.4% -76.8%
TTM Revenue (USD) $1.26B $1.14B
Market Cap $15.0B $6.7B
3. Profitability & Quality OHI
Gross Margin 95.8% 61.9%
Operating Margin 62.6% 13.2%
Net Profit Margin 60.5% -4.0%
Return on Equity (ROE) 14.5% -1.0%
4. Balance Sheet & Cash Flow OHI
Cash Generation (TTM) $855M $169M
Cash Flow Margin 67.9% 14.8%
Net Cash / Leverage $3.83B Net Debt (0.73x D/E) $4.47B Net Debt (1.10x D/E)
Dividend Yield 5.61% 4.98%
5. Options & Positioning OHI
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 26.9% (65th %ile) 25.2% (13th %ile)
Put/Call OI Skew 0.71x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Distribution NEUTRAL · Neutral
6. R&D & Supply-Chain Moat HR
OpEx & R&D Intensity 33.2% of Rev ($418M) 48.7% of Rev ($554M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role REIT - Healthcare Facilities Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: OHI (6) vs HR (3)
Institutional Metric OHI HR Criterion Row Edge
Market Capitalization
Scale
$15.0B $6.7B Larger Scale OHI
Trailing P/E Ratio
Valuation
19.0x 10.8x Lower Multiple HR
Forward P/E Ratio
Valuation
22.6x 10.8x Lower Multiple HR
Revenue Growth (YoY)
Growth
-0.6% -3.6% Higher Growth OHI
Operating Margin (TTM)
Profitability
62.6% 13.2% Higher Margin OHI
Net Profit Margin
Profitability
60.5% -4.0% Higher Margin OHI
Return on Equity (ROE)
Capital Efficiency
14.5% -1.0% Higher ROE OHI
52-Week Range Position
Momentum
46% ($42–$52) 52% ($16–$22) Stronger Trend HR
Beta / 30D Volatility
Risk Regime
-0.04β · 29% Vol 0.11β · 29% Vol Lower Realized Risk Tie
Unified Institutional Score
Composite Signal
50.5 / 100 (HOLD) 43.3 / 100 (HOLD) Higher Composite OHI
Trailing 12M Revenue (USD)
Operating Scale
$1.26B $1.14B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
95.8% 61.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
11.99x PEG · 14.9x EV/Rev 8.82x PEG · 9.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$855M ($3.83B Net Debt (0.73x D/E)) $169M ($4.47B Net Debt (1.10x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HR +7.45 pp
OHI: +2.79% · HR: +10.24%
3M Horizon OHI +0.18 pp
OHI: +1.02% · HR: +0.84%
6M Horizon OHI +2.63 pp
OHI: -2.91% · HR: -5.54%
1Y Horizon OHI +1.39 pp
OHI: +7.97% · HR: +6.58%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period OHI Revenue HR Revenue OHI Op. Margin HR Op. Margin Margin Leader
FY2018 $880M $700M 56.4% 30.7% OHI
FY2019 $930M $690M 59.4% 4.4% OHI
FY2020 $890M $10M N/A 980.0% HR
FY2021 $1.06B $10M N/A 647.7% HR
FY2022 $880M $10M N/A 298.4% HR
FY2023 $950M $20M 25.5% -1594.5% OHI
FY2024 $1.05B $20M 38.6% -3416.4% OHI
FY2025 $1.19B $30M 49.6% -872.1% OHI

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
OHI CONSOLIDATION
80d in phase · OBV DISTRIBUTION
Current IV 26.9%
IV Percentile 65th %ile
Put/Call OI Skew 0.71x (Call-Skewed)
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact OHI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HR CONSOLIDATION
108d in phase · OBV NEUTRAL
Current IV 25.2%
IV Percentile 13th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
OHI Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $15.0B market capitalization and 62.6% operating margin.
OpEx & R&D Reinvestment 33.2% of Rev ($418M)
90D Engineering Disclosures 0 Published
HR Moat Profile Cyclical / Execution-Driven Positioning
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $6.7B market capitalization and 13.2% operating margin.
OpEx & R&D Reinvestment 48.7% of Rev ($554M)
90D Engineering Disclosures 0 Published

Investor FAQ OHI vs HR Key Questions & Quantitative Answers

As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over Healthcare Realty Trust Incorporated (HR) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas HR carries 43.3/100 (HOLD) at $19.27 (10.8x Forward P/E, 13.2% operating margin). Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile HR trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 64.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

OHI leads the Growth & Scale pillar: OHI posts -0.6% YoY revenue growth and -55.4% YoY earnings growth on $1.26B TTM revenue (95.8% gross margin, 62.6% operating margin), compared with HR at -3.6% YoY revenue growth and -76.8% YoY earnings growth on $1.14B TTM revenue (61.9% gross margin, 13.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), OHI cumulative revenue shifted +35.2% while HR shifted -95.7%. In operating R&D and SG&A reinvestment, OHI deploys 33.2% of Rev ($418M) (0 90-day corporate R&D disclosures) versus 48.7% of Rev ($554M) (0 disclosures) for HR.

HR screens cheaper on headline valuation multiples. OHI trades at 22.6x Forward P/E, 19.0x Trailing P/E, 11.99x PEG, and 14.9x EV/Revenue (67.9% FCF margin), whereas HR trades at 10.8x Forward P/E, 10.8x Trailing P/E, 8.82x PEG, and 9.8x EV/Revenue (14.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OHI (14.5% ROE) versus HR (-1.0% ROE) capital efficiency.

In options market volatility and institutional positioning, OHI carries 26.9% implied volatility (65th %ile, Elevated (60th–80th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.04β · 29% Vol realized risk). By comparison, HR carries 25.2% implied volatility (13th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.11β · 29% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.